Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 2400-2499

2400. E.M. Nkamgueu, J.J. Adnet, J. Bernard, K. Zierold, L. Kilian, E. Jallot, H. Benhayoune, P. Bonhomme, “In vitro effects of zirconia and alumina particles on human blood monocyte-derived macrophages: X-ray microanalysis and flow cytometric studies,” J. Biomed. Mater. Res. 52(15 December 2000):587-594.

2401. J.G. Kennedy, W.B. Rodgers, D. Zurakowski, R. Sullivan, D. Griffin, W. Beardsley, L. Sheehan, “Pyrexia after total knee replacement. A cause for concern?” Am. J. Orthop. 26(August 1997):549-552, 554.

2402. S. Guinn, F.P. Castro Jr., R. Garcia, R.L. Barrack, “Fever following total knee arthroplasty,” Am. J. Knee Surg. 12(Summer 1999):161-164.

2403. J.A. Shaw, R. Chung, “Febrile response after knee and hip arthroplasty,” Clin. Orthop. 367(October 1999):181-189.

2404. I.D. Vellar, “The starch granuloma syndrome,” Med. J. Aust. 1(18 January 1975):60-62; J.J. Sternlieb, D.C. McIlrath, J.A. van Heerden, E.G. Harrison Jr., “Starch peritonitis and its prevention,” Arch. Surg. 112(April 1977):458-461.

2405. M. Engoren, “Lack of association between atelectasis and fever,” Chest 107(January 1995):81-84.

2406. I. Perez-Aispuro, J. Perez-Castro, F. Avelar-Garnica, N. Wacher-Rodarte, A. Lifshitz-Guinzberg, “A reconsideration of postoperative fever due to pulmonary atelectasis,” Gac. Med. Mex. 127(January-February 1991):27-30. In Spanish.

2407. R.J. Green, D.E. Clarke, R.S. Fishman, T.A. Raffin, “Investigating the causes of fever in critically ill patients. Are you overlooking noninfectious causes?” J. Crit. Illn. 10(January 1995):51-53, 57-58, 63-64.

2408. R. Ewert, I. Lindemann, B. Romberg, F. Petri, C. Witt, “The accidental aspiration and ingestion of petroleum in a fire eater,” Dtsch. Med. Wochenschr. 117(16 October 1992):1594-1598. In German.

2409. P.A. Tabor, “Drug-induced fever,” Drug Intell. Clin. Pharm. 20(June 1986):413-420.

2410. D.H. Johnson, B.A. Cunha, “Drug fever,” Infect. Dis. Clin. North Am. 10(March 1996):85-91.

2411. L.A. Conger Jr., W.J. Grabski, “Dilantin hypersensitivity reaction,” Cutis 57(April 1996):223-226.

2412. H.M. Lorenz, “Biological agents: a novel approach to the therapy of rheumatoid arthritis,” Expert Opin. Investig. Drugs 9(July 2000):1479-1490.

2413. R.N. Maini, P.C. Taylor, “Anti-cytokine therapy for rheumatoid arthritis,” Annu. Rev. Med. 51(2000):207-229.

2414. H.C. Dees, “A study of the effect of phenergan and vistaril in combination with demerol on labor and delivery,” J. Med. Assoc. Ga. 54(September 1965):301-303.

2415. B.T. Cohn, R.I. Draeger, D.W. Jackson, “The effects of cold therapy in the postoperative management of pain in patients undergoing anterior cruciate ligament reconstruction,” Am. J. Sports Med. 17(May-June 1989):344-349.

2416. M.F. Hasty, W.F. Vann Jr., D.C. Dilley, J.A. Anderson, “Conscious sedation of pediatric dental patients: an investigation of chloral hydrate, hydroxyzine pamoate, and maperidine vs. chloral hydrate and hydroxyzine pamoate,” Pediatr. Dent. 13(January-February 1991):10-19.

2417. R.J. Naylor, J.A. Rudd, “Emesis and anti-emesis,” Cancer Surv. 21(1994):117-135.

2418. A. du Bois, W. Vach, M. Kiechle, U. Cramer-Giraud, H.G. Meerpohl, “Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis,” Oncology 53(June 1996):46-50 (Suppl 1).

2419. H.J. Schmoll, J. Casper, “Management of other non-cisplatin-induced emesis,” Oncology 53(June 1996):51-55 (Suppl 1).

2420. A.A. Fauser, M. Fellhauer, M. Hoffmann, H. Link, G. Schlimok, R.J. Gralla, “Guidelines for anti-emetic therapy: acute emesis,” Eur. J. Cancer 35(March 1999):361-370.

2421. Kenneth R. McQuaid, “Chapter 13. Alimentary Tract,” in Lawrence M. Tierney, Jr., Stephen J. McPhee, Maxine A. Papadakis, eds., Current Medical Diagnosis and Treatment, 35th Edition, Appleton and Lange, Stamford, CT, 1996, pp. 489-575.

2422. Paul Yeaton, Richard W. McCallum, “Nausea and Vomiting,” in J. Willis Hurst, Medicine for the Practicing Physician, Third Edition, Butterworth-Heinemann, Boston MA, 1992, pp. 1494-1497.

2423. K.P. Bhargava, K.S. Dixit, “Role of the chemoreceptor trigger zone in histamine-induced emesis,” Br. J. Pharmacol. 34(November 1968):508-513.

2424. J.B. Wyman, M.R. Wick, “The vomiting patient,” Am. Fam. Physician 21(February 1980):139-143.

2425. S. Bodis, E. Alexander 3rd, H. Kooy, J.S. Loeffler, “The prevention of radiosurgery-induced nausea and vomiting by ondansetron: evidence of a direct effect on the central nervous system chemoreceptor trigger zone,” Surg. Neurol. 42(September 1994):249-252.

2426. S. Tate, H. Cook, “Postoperative nausea and vomiting. 1: Physiology and aetiology,” Br. J. Nurs. 5(12-25 September 1996):962, 964, 966 passim.

2427. P.L. Andrews, J. Hawthorn, “The neurophysiology of vomiting,” Baillieres Clin. Gastroenterol. 2(January 1988):141-168.

2428. A.D. Miller, S. Nonaka, J. Jakus, “Brain areas essential or non-essential for emesis,” Brain Res. 647(6 June 1994):255-264.

2429. A.D. Miller, S. Nonaka, J. Jakus, B.J. Yates, “Modulation of vomiting by the medullary midline,” Brain Res. 737(21 October 1996):51-58.

2430. A.D. Miller, “Central mechanisms of vomiting,” Dig. Dis. Sci. 44(August 1999):31S-38S.

2431. P.L. Andrews, R.J. Naylor, R.A. Joss, “Neuropharmacology of emesis and its relevance to anti-emetic therapy. Consensus and controversies,” Support Care Cancer 6(May 1998):197-203.

2432. P.L. Andrews, “Cyclic vomiting syndrome: timing, targets, and treatment – a basic science perspective,” Dig. Dis. Sci. 44(August 1999):39S-43S.

2433. I.M. Lang, “Noxious stimulation of emesis,” Dig. Dis. Sci. 44(August 1999):58S-63S.

2434. A.S. Manoguerra, E.P. Krenzelok, “Rapid emesis from high-dose ipecac syrup in adults and children intoxicated with antiemetics or other drugs,” Am. J. Hosp. Pharm. 35(November 1978):1360-1362.

2435. J.R. Martin, “Coeliactomy: differential toxiphobia conditioning with apomorphine and copper sulfate,” Pharmacol. Biochem. Behav. 11(September 1979):331-334.

2436. E.P. Bauer, L.J. Fuortes, “An assessment of exposure to mercury and mercuric chloride from handling treated herbarium plants,” Vet. Hum. Toxicol. 41(June 1999):154-156.

2437. W.R. Moore, “Caustic ingestions. Pathophysiology, diagnosis, and treatment,” Clin. Pediatr. (Phila) 25(April 1986):192-196.

2438. A.B. Stefaniwsky, G.S. Tint, J. Speck, S. Shefer, G. Salen, “Ursodeoxycholic acid treatment of bile reflux gastritis,” Gastroenterology 89(November 1985):1000-1004.

2439. A.T. Proudfoot, D. Simpson, E.H. Dyson, “Management of acute iron poisoning,” Med. Toxicol. 1(March-April 1986):83-100.

2440. H.Z. Yang, M.H. Woo, “The effect of various cleansing methods for total fiber optic colonoscopy,” Taehan Kanho 29(30 August 1990):25-35. In Korean.

2441. H.L. Lee, K.W. Chen, M.H. Wu, “Acute poisoning with a herbicide containing imazapyr (Arsenal): a report of six cases,” J. Toxicol. Clin. Toxicol. 37(1999):83-89.

2442. N. Yuasa, K. Miyata, Y. Kobayashi, S. Fukata, T. Hattori, N. Hirabayashi, “Mucosal dysplasia in the bile duct after choledochoduodenostomy: a case report,” Hepatogastroenterology 47(September-October 2000):1238-1240.

2443. K. Neubertova, J. Kotrnoch, Z. Beranova, “Traumatic obstruction of the duodenum,” Rozhl. Chir. 69(August 1990):551-555. In Czech.

2444. S. Hadidy, M.Z. Shammaa, A. Kharma, “Some features of paediatric urolithiasis in a group of Syrian children,” Int. Urol. Nephrol. 19(1987):3-8.

2445. C. Stewart, “Nephrolithiasis,” Emerg. Med. Clin. North Amer. 6(August 1988):617-630.

2446. G. Stringel, S. Mercer, “Idiopathic perforation of the biliary tract in infancy,” J. Pediatr. Surg. 18(October 1983):546-550.

2447. T. Iitomi, S. Toriumi, A. Kondo, T. Akazawa, T. Nakahara, “Incidence of nausea and vomiting after cholecystectomy performed via laparotomy or laparoscopy,” Masui 44(December 1995):1627-1631. In Japanese.

2448. M.A. Kocdor, C. Aydin, H. Astarcioglu, A. Kupelioglu, S. Bora, “Perforated solitary ulcer of the colon. Report of a case,” Dis. Colon Rectum 41(August 1998):1059-1061.

2449. Z.X. Yao, “Diagnostic criteria and their relation to prognosis in acute pancreatitis,” Chung Hua Wai Ko Tsa Chih 27(May 1989):264-266, 316. In Chinese.

2450. M. Rothlin, C. Strittmatter, S. Geroulanos, F. Largiader, “Clinical aspects of acute pancreatitis,” Schweiz. Med. Wochenschr. 119(27 May 1989):752-754. In German.

2451. N.W. Schuitemaker, F.M. Helmerhorst, A. Tjon, R.T. Tham, J.L. van Saase, “Late anaphylactic shock after hysterosalpingography,” Fertil. Steril. 54(September 1990):535-536.

2452. P.J. O’Dwyer, F.P. LaCreta, J.P. Daugherty, M. Hogan, N.G. Rosenblum, J.L. O’Dwyer, R.L. Comis, “Phase I pharmacokinetic study of intraperitoneal etoposide,” Cancer Res. 51(15 April 1991):2041-2046.

2453. A. Boaz, M. Dan, I. Charuzi, O. Landau, Y. Aloni, S. Kyzer, “Pseudomembranous colitis: report of a severe case with unusual clinical signs in a young nurse,” Dis. Colon Rectum 43(February 2000):264-266.

2454. B.J. Yates, A.D. Miller, J.B. Lucot, “Physiological basis and pharmacology of motion sickness: an update,” Brain Res. Bull. 47(15 November 1998):395-406.

2455. A. Rolnick, R.E. Lubow, “Why is the driver rarely motion sick? The role of controllability in motion sickness,” Ergonomics 34(July 1991):867-879.

2456. N. Takeda, M. Morita, S. Hasegawa, A. Horii, T. Kubo, T. Matsunaga, “Neuropharmacology of motion sickness and emesis. A review,” Acta Otolaryngol. Suppl. 501(1993):10-15.

2457. K.C. Chang, J.S. Huang, K.N. Liu, C.S. Tsai, T.Y. Chen, “Neurinoma of the spinal accessory nerve: report of a case,” J. Formos. Med. Assoc. 89(July 1990):593-597.

2458. H. Tsukamoto, T. Matsushima, S. Shono, M. Miyazono, M. Fukui, A. Kondo, “Primary yolk sac tumor of the cerebellar vermis: case report,” Surg. Neurol. 38(July 1992):50-56.

2459. H. Snyder, K. Robinson, D. Shah, R. Brennan, M. Handrigan, “Signs and symptoms of patients with brain tumors presenting to the emergency department,” J. Emerg. Med. 11(May-June 1993):253-258.

2460. R. Quester, J. Menzel, W. Thumfart, “Radical removal of a large glossopharyngeal neurinoma with preservation of cranial nerve functions,” Ear Nose Throat J. 72(September 1993):600-602, 605-608, 611.

2461. D.W. Johns, “Disorders of the central and autonomic nervous systems as a cause for emesis in infants,” Semin. Pediatr. Surg. 4(August 1995):152-156.

2462. A.J. Martinez, C. Sotelo-Avila, H. Alcala, E. Willaert, “Granulomatous encephalitis, intracranial arteritis, and mycotic aneurysm due to a free-living ameba,” Acta Neuropathol. (Berl) 49(1980):7-12.

2463. T. Endo, M. Minami, M. Hirafuji, T. Ogawa, K. Akita, M. Nemoto, H. Saito, M. Yoshioka, S.H. Parvez, “Neurochemistry and neuropharmacology of emesis – the role of serotonin,” Toxicology 153(16 November 2000):189-201.

2464. O. Rascol, T.C. Hain, C. Brefel, M. Benazet, M. Clanet, J.L. Montastruc, “Antivertigo medications and drug-induced vertigo. A pharmacological review,” Drugs 50(November 1995):777-791.

2465. K.M. Doherty, “Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy,” Clin. J. Oncol. Nurs. 3(July 1999):113-119.

2466. A.N. Rizk, P.J. Hesketh, “Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development,” Drugs R.D. 2(October 1999):229-235.

2467. K. Simpson, C.M. Spencer, K.J. McClellan, “Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting,” Drugs 59(June 2000):1297-1315.

2468. G. Egerer, U. Hegenbart, H.J. Salwender, H. Goldschmidt, A.D. Ho, “Treatment of chemotherapy-induced emesis,” Antibiot. Chemother. 50(2000):171-183.

2469. U. Ladabaum, W.L. Hasler, “Novel approaches to the treatment of nausea and vomiting,” Dig. Dis. 17(1999):125-132.

2470. R.J. Naylor, J.A. Rudd, “Emesis and anti-emesis,” Cancer Surv. 21(1994):117-135.

2471. A.L. Kovac, “Prevention and treatment of postoperative nausea and vomiting,” Drugs 59(February 2000):213-243.

2472. A. Woodhouse, L.E. Mather, “Nausea and vomiting in the postoperative patient-controlled analgesia environment,” Anaesthesia 52(August 1997):770-775.

2473. S. Berthoud, F. Rime, P. Buffle, “Amebic liver abscess of unusual presentation,” Schweiz. Med. Wochenschr. 106(12 June 1976):828-830. In French.

2474. M.J. Porcelli, G.M. Gugelchuk, “A trek to the top: a review of acute mountain sickness,” J. Am. Osteopath. Assoc. 95(December 1995):718-720.

2475. J. Bergstrom, “Regulation of appetite in chronic renal failure,” Miner. Electrolyte Metab. 25(July-December 1999):291-297.

2476. N.D. Moulick, S. Banavali, A.D. Abhyankar, S. Borkar, J. Aiyengar, N.M. Kapadia, R.C. Khokhani, “Acute accidental exposure to chlorine fumes – a study of 82 cases,” Indian J. Chest Dis. Allied Sci. 34(April-June 1992):85-89.

2477. F. Cox, “Systematic review of ondansetron for the prevention and treatment of postoperative nausea and vomiting in adults,” Br. J. Theatre Nurs. 9(December 1999):556-563, 566.

2478. J. Herrstedt, M.S. Aapro, J.F. Smyth, A. Del Favero, “Corticosteroids, dopamine antagonists and other drugs,” Support Care Cancer 6(May 1998):204-214.

2479. J. Marin, M.C. Ibanez, S. Arribas, “Therapeutic management of nausea and vomiting,” Gen. Pharmacol. 21(1990):1-10.

2480. N.M. Rupniak, M.S. Kramer, “Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists,” Trends Pharmacol. Sci. 20(December 1999):485-490.

2481. T. Koga, R. Qu, H. Fukuda, “The central pattern generator for vomiting may exist in the reticular area dorsomedial to the retrofacial nucleus in dogs,” Exp. Brain Res. 118(January 1998):139-147.

2482. B.J. Yates, L. Grelot, I.A. Kerman, C.D. Balaban, J. Jakus, A.D. Miller, “Organization of vestibular inputs to nucleus tractus solitarius and adjacent structures in cat brain stems,” Am. J. Physiol. 267(October 1994):R974-R983.

2483. A.D. Miller, R.A. Leslie, “The area postrema and vomiting,” Front. Neuroendocrinol. 15(December 1994):301-320.

2484. Charles A. Linker, “Chapter 12. Blood,” in Lawrence M. Tierney, Jr., Stephen J. McPhee, Maxine A. Papadakis, eds., Current Medical Diagnosis and Treatment, 35th Edition, Appleton and Lange, Stamford, CT, 1996, pp.434-488.

2485. C. Passirani, G. Barratt, J.P. Devissaguet, D. Labarre, “Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system,” Life Sci. 62(1998):775-785.

2486. A. Rolland, F. Paul, K.M. Stott, C.J. Olliff, “Determination of the surface tension of block copolymer micelles by phagocytosis,” Pharm. Res. 12(October 1995):1435-1438.

2487. Michaella Vittaz, Didier Bazile, Gilles Spenlehauer, Thierry Verrechia, Michel Veillard, Francis Puisieux, Denis Labarre, “Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators,” Biomaterials 17(August 1996):1575-1581.

2488. V.P. Torchilin, “Polymer-coated long-circulating microparticulate pharmaceuticals,” J. Microencapsul. 15(January-February 1998):1-19.

2489. V.S. Trubetskoy, G.S. Gazelle, G.L. Wolf, V.P. Torchilin, “Block-copolymer of polyethylene glycol and polylysine as a carrier of organic iodine: design of long-circulating particulate contrast medium for X-ray computed tomography,” J. Drug Target. 4(1997):381-388.

2490. C. Passirani, G. Barratt, J.P. Devissaguet, D. Labarre, “Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate),” Pharm. Res. 15(July 1998):1046-1050.

2491. M.A. Monck, A. Mori, D. Lee, P. Tam, J.J. Wheeler, P.R. Cullis, P. Scherrer, “Stabilized plasmid-lipid particles: pharmacokinetics and plasmid delivery to distal tumors following intravenous injection,” J. Drug Target. 7(2000):439-452.

2492. C.R. Merril, B. Biswas, R. Carlton, N.C. Jensen, G.J. Creed, S. Zullo, S. Adhya, “Long-circulating bacteriophage as antibacterial agents,” Proc. Natl. Acad. Sci. (USA) 93(16 April 1996):3188-3192.

2493. D.M. Bernstein, R.T. Drew, M. Kuschner, “Experimental approaches for exposure to sized glass fibers,” Environ. Health Perspect. 34(February 1980):47-57.

2494. G. Oberdorster, “Determinants of the pathogenicity of man-made vitreous fibers,” Int. Arch. Occup. Environ. Health 73(June 2000):S60-S68.

2495. J. Heyder, “Alveolar deposition of inhaled particles in humans,” Am. Ind. Hyg. Assoc. J. 43(November 1982):864-866; J.E. Agnew, D. Pavia, S.W. Clarke, “Factors affecting the `alveolar deposition’ of 5 microns inhaled particles in healthy subjects,” Clin. Phys. Physiol. Meas. 6(February 1985):27-36.

2496. S. Dogra, J.L. Kaw, “Changes in some histochemically demonstrable enzymes in macrophages exposed to quartz dust in vitro,” J. Appl. Toxicol. 8(February 1988):23-27.

2497. D.N. Rushton, G.S. Brindley, C.E. Polkey, G.V. Browning, “Implant infections and antibiotic-impregnated silicone rubber coating,” J. Neurol. Neurosurg. Psychiatry 52(February 1989):223-229

2498. J.D. Blaha et al, “The use of septopal (polymethylmethacrylate beads with gentamicin) in the treatment of chronic osteomyelitis,” Instr. Course Lect. 39(1990):509-514.

2499. M.H. Henderson Jr., R.E. Booth Jr., “The use of an antibiotic-impregnated spacer block for revision of the septic total knee arthroplasty,” Semin. Arthroplasty 2(January 1991):34-39; R.E. Booth Jr., P.A. Lotke, “The results of spacer block technique in revision of infected total knee arthroplasty,” Clin. Orthop. 248(November 1989):57-60.


Last updated on 16 April 2004